8-K
Current Report
Fulcrum Therapeutics, Inc. Filed Acc 0001193125-26-178806
Agreement ended · Results of operations · Executive or director change
- Item 1.02 Termination of a material definitive agreement
- Item 2.02 Results of operations and financial condition
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading fulc-20260423.htm…